Mariette, X., Clowse, M., Förger, F., Hwang, C., Thorp, J., Dolhain, R. J., … Hale, T. W. (2016). Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study. Revue Du Rhumatisme (Edition Francaise), 83, A100–A102. https://doi.org/10.1016/S1169-8330(16)30359-3

Mariette, X., M. Clowse, F. Förger, C. Hwang, J. Thorp, R. J. Dolhain, A. Van Tubergen, et al. “Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study.” Revue Du Rhumatisme (Edition Francaise) 83 (November 1, 2016): A100–102. https://doi.org/10.1016/S1169-8330(16)30359-3.

Mariette X, Clowse M, Förger F, Hwang C, Thorp J, Dolhain RJ, et al. Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study. Revue du Rhumatisme (Edition Francaise). 2016 Nov 1;83:A100–2.

Mariette, X., et al. “Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study.” Revue Du Rhumatisme (Edition Francaise), vol. 83, Nov. 2016, pp. A100–02. Scopus, doi:10.1016/S1169-8330(16)30359-3.

Mariette X, Clowse M, Förger F, Hwang C, Thorp J, Dolhain RJ, Van Tubergen A, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW. Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study. Revue du Rhumatisme (Edition Francaise). 2016 Nov 1;83:A100–A102.